BWM
ABMD

Buckley Wealth Management’s Abiomed Inc ABMD Stock Holding History

Buckley Wealth Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-800
Closed -$208K – 153
2019
Q2 		$208K Hold
800
– – 0.1% 141
2019
Q1 		$228K Hold
800
– – 0.11% 136
2018
Q4 		$260K Hold
800
– – 0.13% 127
2018
Q3 		$360K Hold
800
– – 0.16% 121
2018
Q2 		$327K Hold
800
– – 0.15% 122
2018
Q1 		$233K Buy
+800
New +$203K 0.12% 146

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Buckley Wealth Management's ABMD Position: Q3 2019 in Review

Buckley Wealth Management sold out of Abiomed Inc (ABMD) in Q3 2019, closing a stake of 800 shares — an estimated $208K sold.

Buckley Wealth Management first reported a position in ABMD in Q1 2018 and held it in 6 quarters. The position peaked at $360K in Q3 2018. 443 funds tracked by Wall St. Rank hold ABMD as of Q3 2019.

  • Buckley Wealth Management reported no remaining Abiomed Inc position as of Q3 2019 after selling out during the quarter.
  • Buckley Wealth Management sold 800 Abiomed Inc shares in Q3 2019, an estimated $208K.
  • Buckley Wealth Management first reported a position in Abiomed Inc in Q1 2018 and held it in 6 quarters.
  • Buckley Wealth Management's Abiomed Inc position peaked at $360K in Q3 2018.
  • 443 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2019.

Based on Buckley Wealth Management's 13F filing for Q3 2019, filed 11 Oct 2019.